Scientific paper - Original scientific paper
A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference
Journal of Infection, 86 (2023), 2; 154-225. https://doi.org/10.1016/j.jinf.2022.11.011

Marčec, Robert; Dodig, Vinko Michael; Likić, Robert

Cite this document

Marčec, R., Dodig, V. M. & Likić, R. (2023). A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference. Journal of Infection, 86. (2), 154-225. doi: 10.1016/j.jinf.2022.11.011

Marčec, Robert, et al. "A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference." Journal of Infection, vol. 86, no. 2, 2023, pp. 154-225. https://doi.org/10.1016/j.jinf.2022.11.011

Marčec, Robert, Vinko Michael Dodig and Robert Likić. "A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference." Journal of Infection 86, no. 2 (2023): 154-225. https://doi.org/10.1016/j.jinf.2022.11.011

Marčec, R., Dodig, V. M. and Likić, R. (2023) 'A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference', Journal of Infection, 86(2), pp. 154-225. doi: 10.1016/j.jinf.2022.11.011

Marčec R, Dodig VM, Likić R. A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference. Journal of Infection [Internet]. 2023 February [cited 2024 May 05];86(2):154-225. doi: 10.1016/j.jinf.2022.11.011

R. Marčec, V. M. Dodig and R. Likić, "A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference", Journal of Infection, vol. 86, no. 2, pp. 154-225, February 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:939974. [Accessed: 05 May 2024]